How to cite item

Tyrosine kinase inhibitors interstitial pneumonitis: diagnosis and management

   
@article{TLCR28967,
	author = {Yayi He and Caicun Zhou},
	title = {Tyrosine kinase inhibitors interstitial pneumonitis: diagnosis and management},
	journal = {Translational Lung Cancer Research},
	volume = {8},
	number = {Suppl 3},
	year = {2019},
	keywords = {},
	abstract = {Lung cancer is the most common cancer in the world (1-3). In the past 10 years, studies have shown that tyrosine kinase inhibitors (TKIs), such as gefitinib, afatinib, and crizotinib, provide significant benefits to advanced non-small cell lung cancer (NSCLC) patients (4,5). NSCLC with positive epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK) mutations can achieve longer progression-free survival (PFS) and a higher life quality through treatment with TKIs (4,5).},
	issn = {2226-4477},	url = {https://tlcr.amegroups.org/article/view/28967}
}